Analysts lifted targets across several sectors today. Micron Technology saw the boldest move. The consensus target jumped from $945 to $1,009 — a 6.7% increase. The memory chip maker carries a $1.3 trillion market cap. Thirty-eight analysts hold Buy ratings against just one Sell.
Incyte Corporation picked up an upgrade from Truist Securities. The biotech's target rose to $105 from $103. The consensus also shifted higher, with one Hold converted to a Buy. Short interest sits at 6.5% of free float — modest for a biotech name.
Goldman Sachs initiated Estée Lauder with a Buy rating and a $100 target. The cosmetics giant has struggled over the past two years. Goldman's call signals confidence in a recovery. Fourteen analysts currently hold Hold ratings, so the bullish initiation stands out.
Robinhood Markets also received a target price upgrade. The consensus average moved to $101.24 from $101.15. At an $85 billion market cap, the fintech broker has grown sharply. Analyst sentiment remains firmly bullish with 19 Buy ratings and just three Sells.
Bank of America rounded out the upgrades with a target lift to $63.34. The banking giant holds the broadest analyst coverage in today's batch.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
